TAM Global Study Challenges Stem Cell Claims for Wharton's Jelly Commercial Products
PR Newswire —
NASHVILLE, Tenn., Jan. 29, 2026 /PRNewswire/ -- TAM Global announced today the publication of a peer-reviewed study demonstrating that commercially available Wharton's jelly products do not contain clinically meaningful levels of viable stem cells. The article, "Critical Evaluation of...